IFF Q2 2026: Divestitures on the Menu, a Bold Buyback, and a Guided Path Forward

By a finance writer who pretends to be a trench-coat economist, channeling Matt Levine

Snapshot for the ticker IFF (NYSE: IFF)

IFF reported its second-quarter 2026 results for the quarter ended June 30, 2026. The company presents results on a continuing operations basis, excluding the Food Ingredients disposal group and other minor perimeter adjustments (the “Food Ingredients disposal group”) and the Soy Crush, Concentrates, and Lecithin businesses (the “SCL disposal group”), which are treated as discontinued operations. In plain words: the numbers you’re supposed to think about are the ones that come from the core, not the parts it’s pruning away.

Second Quarter 2026 Consolidated Summary (continuing operations)

The press release provides a concise read on the core business:

Sales: $2.0 billion
Income before taxes: $64 million
EPS: $0.13
Operating EBITDA: approximately $408 million

The figures above reflect continuing operations, with the legacy Food Ingredients and SCL disposal groups treated as discontinued. In other words, the company is handing you the core business without the ash from a couple of firework displays it’s planning to extinguish.

Importantly, the release emphasizes the ongoing nature of the business metrics rather than the disposed assets. There’s no explicit EPS consensus or earnings surprise disclosed in this excerpt, so investors are left to judge the quarterly result on the disclosed continuing-ops numbers and the accompanying guidance.

Strategic moves: divestitures and capital allocation

The press release flags a deliberate portfolio reconfiguration:

Plans tied to Food Ingredients disposal: a foundation for use of proceeds—i.e., capital that can be redeployed elsewhere rather than parked in non-core assets.
Disposition of SCL assets (Soy Crush, Concentrates, Lecithin) classified as discontinued operations, narrowing the scope of reported results to the core business.
Capital returns: an enhanced $2.5 billion share repurchase authorization, including a $500 million Accelerated Share Repurchase (ASR) in the second half of 2026. Translation: the company is comfortable returning cash to shareholders while it reshapes the asset base.

These moves are a classic portfolio-management play: monetize non-core pieces, focus on the cash generator, and use buybacks to lift per-share metrics while the strategic narrative for growth continues to evolve.

Guidance and outlook

IFF issued full-year 2026 financial guidance on a continuing operations basis. The report emphasizes comparability by excluding the Food Ingredients disposal group and the SCL disposal group from ongoing results, which helps investors judge the core business without the noise of asset sales. The release positions the revenue forecast for the core business within the continuing-ops framework, but it does not present a detailed number here in the excerpt.

For readers who care about the math, the real story is not just the quarterly EPS of $0.13 or the $408 million operating EBITDA, but whether the continued cash-flow generation supports the new $2.5B buyback and the implied confidence in the core margin profile. The guidance will matter more than headline quarterly results if the company can sustain or improve margins while the asset-sale timing shapes the realized cash available for returns.

What this portends for IFF and peers

The quarter reads like a recalibration: extract the cash-generating core, monetize non-core assets, and lean on the capital-return toolkit to keep investors engaged. The explicit separation of continuing operations from disposed assets makes the core earnings story more defensible in a volatile macro backdrop, but it also leaves questions about growth rates if the core business weathered cycles through the Food Ingredients portfolio.

In terms of market signaling, this mix of divestitures and a large buyback aligns with a broader pattern among large-cap players facing asset-lighting opportunities. It also creates a clean comparison point for sector peers in flavors, fragrances, and ingredient specialties. If IFF can sustain a robust operating EBITDA level while the asset disposal proceeds unwind, expect peers to weigh similar moves—either pruning legacy assets or accelerating buybacks to support EPS in the near term.

From an earnings-discussion lens, investors will watch for:

Whether the continuing ops revenue trajectory matches the stated revenue forecast for 2026.
Any shifts in margin structure as the company concentrates its portfolio on higher-return core assets.
Actual deployment of proceeds from asset sales and the pace of cash generation post-divestiture.

The market tends to reward clarity on cash returns when growth options are narrowed. The $2.5B buyback, including a $500M ASR, is a direct nod to capital discipline—profitability in a buyback wrapper can lift EPS in the near term even if the growth runway remains murky. For sector peers, the takeaway is simple: if you can extract non-core pieces and still fund a sizable buyback while maintaining a credible continuing-ops narrative, you’ve just engineered a more attractive EPS trajectory, at least on a per-share basis.

Key takeaways

Ticker: IFF; Results presented on continuing operations, with disposed assets excluded.
EPS: $0.13 for the quarter on continuing operations.
Revenue/Sales: ~$2.0B in the quarter for continuing operations.
Disposals: Food Ingredients and SCL disposal groups treated as discontinued; focus remains on core business.
Capital allocation: $2.5B share repurchase authorization, including a $500M ASR in H2 2026.
Guidance: Full-year 2026 financial guidance provided on a continuing-operations basis; revenue forecast framed around the core business.
Analytical note: No explicit EPS consensus or earnings surprise disclosed in the excerpt; emphasis on the strategy and cash-return plan.